Letter to the Editor
Incidence of SARS-CoV-2 Infection in Asthma Patients on Omalizumab Therapy
1Division of Allergy and Immunology, Department of Pediatrics, Sakarya University Faculty of Medicine, Training and Research Hospital, Sakarya, Türkiye
J Clin Pract Res 2022; 44(5): 533-534 DOI: 10.14744/etd.2022.28938
Keywords: Omalizumab, SARS-CoV-2, COVID-19, Chronic Spontaneous Urticaria, asthma